Trials / Sponsors / Vergent Bioscience, Inc.
Vergent Bioscience, Inc.
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surg Lung Cancer, Lung Metastases | Phase 3 | 2026-03-01 |
| Completed | Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung. Lung Cancer, Lung Metastases | Phase 2 | 2023-10-05 |
| Completed | Phase 2 Study of VGT-309 in Lung Cancer Lung Cancer | Phase 2 | 2022-05-24 |